A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey Memorial Sloan Kettering Monmouth, Middletown, New Jersey Memorial Sloan Kettering Bergen, Montvale, New Jersey Memorial Sloan Kettering Suffolk - Commack, Commack, New York Memorial Sloan Kettering Westchester, Harrison, New York Memorial Sloan Kettering Cancer Center, New York, New York Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York Age range
18 Years and older
Last updated November 2025